DUBLIN–(BUSINESS WIRE)–The “Global Cervical Dysplasia Market (2022-2027) by Diagnostics Type, Treatment Type, End-users, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Cervical Dysplasia Market is estimated to be worth USD 704.34 million in 2022, and is expected to reach USD 977.76 million by 2027, growing at a CAGR of 6.78%.
Market Segmentation
The Global Cervical Dysplasia Market is segmented based on Diagnostics Type, Treatment Type, End-users, and Geography.
- By Diagnostics Type, the market is classified into Biopsy, Colposcopy, HPV Test, and Pap Smear Test.
- By Treatment Type, the market is classified into Chemotherapy, Radiation Therapy, Surgery, and Therapeutic HPV Vaccines.
- By End-users, the market is classified into Ambulatory Surgery Centers, Diagnostic Centers, Hospitals, Research & Academic Institutes, and Specialty Clinics.
- By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.
The Competitive Quadrant
The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
- The report presents a detailed Ansoff matrix analysis for the Global Cervical Dysplasia Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
- The Global Cervical Dysplasia Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
- Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.
Why Buy This Report?
- The report offers a comprehensive evaluation of the Global Cervical Dysplasia Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
- The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.
- The report also contains competitive analysis using ‘Positioning Quadrants’; a proprietary competitive positioning tool.
Market Dynamics
Drivers
- Increasing Incidences of Cervical Cancer
- Rising Initiatives by the Government to Enhance the Screening of Cervical Dysplasia
- Emergence of Cervical Screening Programs
Restraints
- High Cost of Diagnostic Devices
Opportunities
- Increasing Awareness Campaigns for the Early Diagnosis
- Technological Advancements in Screening Devices and Other Supporting Equipment
- Challenges
- Alteration in Regulatory Guidelines for Cervical Cancer Screening and Use of HPV Vaccines
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Cervical Dysplasia Market, by Diagnostics Type
7 Global Cervical Dysplasia Market, by Treatment Type
8 Global Cervical Dysplasia Market, by End-users
9 Americas’ Cervical Dysplasia Market
10 Europe’s Cervical Dysplasia Market
11 Middle East and Africa’s Cervical Dysplasia Market
12 APAC’s Cervical Dysplasia Market
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
- Abbott Laboratories
- Asieris Pharmaceuticals
- ASKA Pharmaceutical Co. Ltd.
- Becton, Dickinson, and Company
- BetterLife Pharma, Inc.
- Bristol-Myers Squibb Company
- Cardinal Health, Inc.
- CooperSurgical, Inc.
- DYSIS Medical Ltd.
- F. Hoffmann La-Roche Ltd.
- GlaxoSmithKline PLC
- Guided Therapeutics, Inc.
- Helix BioPharma Corp.
- Hologic, Inc.
- Karl Kaps GmbH & Co. KG
- KinoPharma, Inc.
- Micromedic Technologies Ltd.
- OncoHealth Corp.
- PDS Biotechnology Company
- Polaris Pharmaceuticals, Inc.
- Qiagen N.V.
- Quest Diagnostics, Inc.
- ViciniVax B.V.
For more information about this report visit https://www.researchandmarkets.com/r/lebtho
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900